Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Adial Pharmaceuticals (ADIL) Restructuring Costs (2022 - 2023)

Adial Pharmaceuticals' Restructuring Costs history spans 2 years, with the latest figure at $15895.0 for Q4 2023.

  • For Q4 2023, Restructuring Costs fell 57.49% year-over-year to $15895.0; the TTM value through Dec 2023 reached $471326.0, changed N/A, while the annual FY2023 figure was $471326.0, 104.07% up from the prior year.
  • Restructuring Costs for Q4 2023 was $15895.0 at Adial Pharmaceuticals, down from $403530.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $403530.0 in Q3 2023 and bottomed at -$289233.0 in Q2 2023.